EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents — A retrospective study of 240 patients

Ruxandra Coropciuc, Renaat Coopman, Melisa Garip, Evelien Gielen, Constantinus Politis, Tim Van den Wyngaert, Benoit Beuselinck

Bone · 2023-05 · 170 · 116722

DOI: 10.1016/j.bone.2023.116722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2023-05. Verfasst von Ruxandra Coropciuc und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, University Hospital of Leuven, Belgium. Electronic address: Ruxandra.coropciuc@uzleuven.be. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Bisphosphonate-Associated Osteonecrosis of the Jaw, Osteoporosis, Bone Neoplasms. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kom op tegen Kanker.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the incidence, risk factors, and outcome of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents for osteoporosis or bone metastases. 240 patients with a median drug exposure of 43 months were retrospectively studied. The incidence of MRONJ after dental extraction in the osteoporosis cohort was 2.7 % per person-year (95 % CI 1.6-4.6 %) (n = 13/126), and for the bone metastases cohort 26.4 % per person-year (95 % CI 20.4-34.2 %) (n = 58/114). 92 % of MRONJ cases were stage 1. Dental infection as the reason for extraction increased the osteonecrosis risk in the osteoporosis (OR 22.77; 95 % CI 2.85-181.62; p = 0.003) and bone metastases cohorts (OR 2.72; 95 % CI 1.28-5.81; p = 0.010). Using leukocyte and platelet-rich fibrin reduced this risk by 84 % (p = 0.003), as did antibiotics use by 86-93 % (p = 0.013). Within the bone metastases cohort, an interval since last administration of at least 3 months reduced risk of MRONJ (OR 0.83; 95 % CI 0.72-0.97; p = 0.018). Mucosal healing occurred in 11/13 patients (84.6 %; 95 % CI 54.5-98.1 %) with osteoporosis and 31/58 patients (53.4 %; 95 % CI 40.0-66.7 %) with bone metastases. In conclusion, though the MRONJ risk in this selected population taking antiresorptive agents and presenting to the Oral Maxillofacial Surgery clinic for a dental extraction is considerable and higher in those with dental infections, preventive measures such as antibiotics and use of LRPF membranes may significantly reduce that risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Density Conservation AgentsBisphosphonate-Associated Osteonecrosis of the JawOsteoporosisBone NeoplasmsHumansRetrospective StudiesAnti-Bacterial AgentsTooth ExtractionDiphosphonates

Stichwörter der Autor:innen

Antiresorptive agentsBone metastasesDental extractionOncologyOsteonecrosisOsteoporosis

Substanzen

Bone Density Conservation AgentsAnti-Bacterial AgentsDiphosphonates

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, University Hospital of Leuven, Belgium. Electronic address: Ruxandra.coropciuc@uzleuven.be.
  • Department of Oral and Maxillofacial and Plastic Surgery, University Hospital of Ghent, Belgium.
  • Department of Oral and Maxillofacial Surgery, University Hospital of Leuven, Belgium.
  • Department of Geriatrics, University Hospital of Leuven, Belgium.
  • Department of Nuclear Medicine, University Hospital of Antwerp, Belgium.
  • Department of Medical Oncology, University Hospital of Leuven, Belgium.

Förderung

  • Kom op tegen Kanker

Zitieren

APA

Coropciuc, R., Coopman, R., Garip, M., Gielen, E., Politis, C., Van den Wyngaert, T., & Beuselinck, B. (2023). Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents — A retrospective study of 240 patients. Bone, 170, 116722. https://doi.org/10.1016/j.bone.2023.116722

Vancouver

Coropciuc R, Coopman R, Garip M, Gielen E, Politis C, Van den Wyngaert T, et al. Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents — A retrospective study of 240 patients. Bone. 2023;170:116722. doi:10.1016/j.bone.2023.116722

BibTeX
@article{Coropciuc2023,
  author = {Coropciuc, Ruxandra and Coopman, Renaat and Garip, Melisa and Gielen, Evelien and Politis, Constantinus and Van den Wyngaert, Tim and Beuselinck, Benoit},
  title = {Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents — A retrospective study of 240 patients},
  journal = {Bone},
  year = {2023},
  volume = {170},
  pages = {116722},
  doi = {10.1016/j.bone.2023.116722}
}
Kostenlos starten →